SO
ADVM

STRS Ohio’s Adverum Biotechnologies ADVM Stock Holding History

STRS Ohio’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$10K – 2154
2020
Q3 		$10K Hold
100
– – ﹤0.01% 2130
2020
Q2 		$20K Buy
+100
New +$17.7K ﹤0.01% 2041
2015
Q3 		– Sell
-230
Closed -$29.4K – 1873
2015
Q2 		$37K Hold
230
– – ﹤0.01% 1785
2015
Q1 		$93K Sell
230
-10
-4% -$4.23K ﹤0.01% 1620
2014
Q4 		$130K Hold
240
– – ﹤0.01% 1514
2014
Q3 		$82K Buy
+240
New +$71.4K ﹤0.01% 1595

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

STRS Ohio's ADVM Position: Q4 2020 in Review

STRS Ohio sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 100 shares — an estimated $10K sold.

STRS Ohio first reported a position in ADVM in Q3 2014 and held it in 6 quarters. The position peaked at $130K in Q4 2014. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • STRS Ohio reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 100 Adverum Biotechnologies shares in Q4 2020, an estimated $10K.
  • STRS Ohio first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 6 quarters.
  • STRS Ohio's Adverum Biotechnologies position peaked at $130K in Q4 2014.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.